I-Mab (IMAB) Short Interest Ratio & Short Volume → “Crash Insurance” For Your Retirement (From Unstoppable Prosperity) (Ad) Free IMAB Stock Alerts $1.79 -0.03 (-1.65%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media I-Mab Short Interest DataCurrent Short Volume1,300,000 sharesPrevious Short Volume1,170,000 sharesChange Vs. Previous Month+11.11%Dollar Volume Sold Short$2.34 millionShort Interest Ratio / Days to Cover3.4Last Record DateApril 15, 2024Outstanding Shares80,880,000 sharesPercentage of Shares Shorted1.61%Today's Trading Volume96,262 sharesAverage Trading Volume424,445 sharesToday's Volume Vs. Average23% Short Selling I-Mab ? Sign up to receive the latest short interest report for I-Mab and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIMAB Short Interest Over TimeIMAB Days to Cover Over TimeIMAB Percentage of Float Shorted Over Time Ad Behind the MarketsFidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>> I-Mab Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,300,000 shares $2.34 million +11.1%N/A3.4 $1.80 3/31/20241,170,000 shares $2.18 million +7.3%N/A2.7 $1.86 3/15/20241,090,000 shares $2.03 million +1.9%N/A2 $1.86 2/29/20241,070,000 shares $1.90 million -5.3%N/A1.9 $1.78 2/15/20241,130,000 shares $2.00 million -28.0%N/A2 $1.77 1/31/20241,570,000 shares $2.78 million +4.0%N/A2.6 $1.77 Get the Latest News and Ratings for IMAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for I-Mab and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,510,000 shares $3.10 million -6.8%N/A2.4 $2.05 12/31/20231,620,000 shares $3.08 million -11.5%N/A2.5 $1.90 12/15/20231,830,000 shares $2.54 million -1.6%N/A3.1 $1.39 11/30/20231,860,000 shares $2.90 million -2.6%N/A2.7 $1.56 11/15/20231,910,000 shares $3.29 million No ChangeN/A2.5 $1.72 10/31/20231,910,000 shares $2.73 million +26.5%N/A2.4 $1.43 10/15/20231,510,000 shares $2.02 million +11.0%N/A2.2 $1.34 9/30/20231,360,000 shares $1.80 million -25.3%N/A2.1 $1.32 9/15/20231,820,000 shares $2.44 million +11.7%N/A3 $1.34 8/31/20231,630,000 shares $3.10 million -0.6%N/A3.5 $1.90 8/15/20231,640,000 shares $3.92 million +7.9%N/A4.8 $2.39 7/31/20231,520,000 shares $4.38 million -4.4%N/A5 $2.88 7/15/20231,590,000 shares $4.44 million +3.9%N/A5.3 $2.79 6/30/20231,530,000 shares $4.57 million -1.9%N/A5.4 $2.99 6/15/20231,560,000 shares $4.80 million +0.7%N/A4.6 $3.08 5/31/20231,550,000 shares $4.81 million -5.5%N/A4.5 $3.10 5/15/20231,640,000 shares $5.33 million -13.7%N/A4.7 $3.25 4/30/20231,900,000 shares $5.85 million -5.9%N/A5.1 $3.08 4/15/20232,020,000 shares $7.11 million +8.6%N/A5.1 $3.52 3/31/20231,860,000 shares $6.44 million +10.1%N/A3.9 $3.46 3/15/20231,690,000 shares $6.54 million -7.1%N/A2.9 $3.87 2/28/20231,820,000 shares $7.83 million -6.7%N/A3.1 $4.30 2/15/20231,950,000 shares $8.89 million -16.7%N/A3.3 $4.56 1/31/20232,340,000 shares $14.09 million +13.0%N/A3.9 $6.02 1/15/20232,070,000 shares $15.30 million +9.5%N/A3.7 $7.39 12/30/20221,890,000 shares $7.90 million -3.1%N/A3.4 $4.18 12/15/20221,950,000 shares $7.29 million +3.7%N/A4.7 $3.74 11/30/20221,880,000 shares $6.96 million -11.7%N/A4.2 $3.70 11/15/20222,130,000 shares $10.35 million +2.9%N/A4.2 $4.86 10/31/20222,070,000 shares $7.68 million -5.9%N/A3.3 $3.71 10/15/20222,200,000 shares $8.21 million -22.8%N/A3.2 $3.73 9/30/20222,850,000 shares $11.43 million +9.2%N/A4.4 $4.01 9/15/20222,610,000 shares $14.15 million -2.3%N/A4 $5.42 8/31/20222,670,000 shares $16.37 million -2.9%N/A3.9 $6.13Elon Musk Secret Crypto Plot Exposed (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. IMAB Short Interest - Frequently Asked Questions What is I-Mab's current short interest? Short interest is the volume of I-Mab shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 1,300,000 shares of IMAB short. Learn More on I-Mab's current short interest. What is a good short interest ratio for I-Mab? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMAB shares currently have a short interest ratio of 3.0. Learn More on I-Mab's short interest ratio. Is I-Mab's short interest increasing or decreasing? I-Mab saw a increase in short interest in April. As of April 15th, there was short interest totaling 1,300,000 shares, an increase of 11.1% from the previous total of 1,170,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does I-Mab's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to I-Mab: InterCure Ltd. (0.21%), Regulus Therapeutics Inc. (10.92%), CervoMed Inc. (0.71%), Incannex Healthcare Inc. (0.36%), Adicet Bio, Inc. (9.55%), Repare Therapeutics Inc. (2.13%), DiaMedica Therapeutics Inc. (0.46%), Prelude Therapeutics Incorporated (1.79%), PDS Biotechnology Co. (19.47%), Sagimet Biosciences Inc. (12.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short I-Mab stock? Short selling IMAB is an investing strategy that aims to generate trading profit from I-Mab as its price is falling. IMAB shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against I-Mab? A short squeeze for I-Mab occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IMAB, which in turn drives the price of the stock up even further. How often is I-Mab's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMAB, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: INCR Short Squeeze RGLS Short Squeeze CRVO Short Squeeze IXHL Short Squeeze ACET Short Squeeze RPTX Short Squeeze DMAC Short Squeeze PRLD Short Squeeze PDSB Short Squeeze SGMT Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IMAB) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityGold Set to EXPLODE!Gold Safe ExchangeThe AI Stock that’s Disrupting Every IndustryStockEarningsShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold